Technical Analysis for IMPL - Impel NeuroPharma, Inc.

Grade Last Price % Change Price Change
B 12.73 0.79% 0.10
IMPL closed up 0.79 percent on Wednesday, July 28, 2021, on 46 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical IMPL trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.79%
Boomer Buy Setup Bullish Swing Setup 0.79%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.79%
Calm After Storm Range Contraction 0.79%
Inside Day Range Contraction 0.79%
Wide Bands Range Expansion 0.79%
Older End-of-Day Signals for IMPL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Down 2 % about 17 hours ago
Down 1% about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Impel NeuroPharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa for the treatment of OFF episodes in Parkinson's disease. Impel NeuroPharma, Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Parkinson's Disease Migraine Central Nervous System Disease Treatment Of Migraine Autism Spectrum Disorder Prodrugs Carbidopa L Dopa Catecholamines Combination Drugs Late Stage Pharmaceutical

Is IMPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.89
52 Week Low 6.93
Average Volume 77,525
200-Day Moving Average 0.00
50-Day Moving Average 10.50
20-Day Moving Average 10.59
10-Day Moving Average 11.83
Average True Range 1.05
ADX 36.56
+DI 37.36
-DI 9.91
Chandelier Exit (Long, 3 ATRs) 12.08
Chandelier Exit (Short, 3 ATRs) 11.00
Upper Bollinger Bands 13.69
Lower Bollinger Band 7.50
Percent B (%b) 0.85
BandWidth 58.41
MACD Line 0.75
MACD Signal Line 0.38
MACD Histogram 0.3748
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.95
Resistance 3 (R3) 13.91 13.48 13.74
Resistance 2 (R2) 13.48 13.17 13.49 13.67
Resistance 1 (R1) 13.10 12.98 12.89 13.14 13.61
Pivot Point 12.67 12.67 12.56 12.68 12.67
Support 1 (S1) 12.29 12.36 12.08 12.33 11.85
Support 2 (S2) 11.86 12.17 11.87 11.79
Support 3 (S3) 11.48 11.86 11.72
Support 4 (S4) 11.52